All posts by: Michael Zand

About Michael Zand

Regenexx® Announces Issue of United States Patent on Proprietary Orthopedic … – OrthoSpineNews

Continue reading

2015-11-02

OrthoSpineNews

Regenexx® Announces Issue of United States Patent on Proprietary Orthopedic
OrthoSpineNews
DENVER, Oct. 28, 2015 /PRNewswire/ — Regenexx® today announced the recent issue of a US Patent on their proprietary same day stem cell procedure used to treat joint injuries, spine pain and degenerative orthopedic conditions, such as osteoarthritis.

Continue reading

2015-11-02

Genetic Engineering & Biotechnology News

Global Stem Cell Banking Market 2015 Analysis and Forecasts to 2019
Medgadget.com (blog)
WiseGuy-Reports26 Stem cells are the building blocks of the human body. They originate in the earliest stage of human development and can be found in the various stages of growth from birth till adulthood. When these undifferentiated biological cells
Gene Found that Regulates Stem Cell Number ProductionGenetic Engineering & Biotechnology News
Parker Road Veterinary Hospital is Now Offering Stem Cell Therapy for Dogs and PR Web (press release)

all 4 news articles »

Continue reading

2015-11-02

Genetic Engineering & Biotechnology News

Gene Found that Regulates Stem Cell Number Production
Genetic Engineering & Biotechnology News
Called Prkci, the gene influences whether stem cells self-renew to produce more stem cells, or differentiate into more specialized cell types, such as blood or nerves. When it comes to stem cells, too much of a good thing isn’t necessarily a benefit

and more »

Continue reading

2015-11-02

LocalGov

Council launches drive to register stem cell donors
LocalGov
Glasgow’s teenagers are encouraging Scotland’s young people to sign-up to be life-saving stem cell donors. A pioneering scheme from Anthony Nolan, the world’s first bone marrow register, and Glasgow City Council has seen 23 pupils from Shawlands …

Continue reading

2015-11-02

Winnipeg Free Press

Questionable stemcell treatment case still under investigation
Winnipeg Free Press
Regenetek is Broeska’s Winnipeg-based company that charged roughly 70 multiple sclerosis and ALS patients from around the world as much as $45,000 to be part of a stemcell clinical trial at a hospital in India. The stem cell treatment promised